ADAPY Adaptimmune Therapeutics PLC: institutional ownership and insider trading
2 funds reported holding $1.12K of Adaptimmune Therapeutics PLC in their latest 13F filings; in Q2 2026 funds net bought $0, with 0 new positions and 1 funds selling out; over the last 12 months insiders bought $0 and sold $0 on the open market.
Largest institutional holders of ADAPY
- Lindbrook Capital, LLC — $908
- Sandy Spring Bank — $207
Recent ADAPY insider trades
- Sep 2, 2025: Wood Gavin sold 96,000 shares ($960)
- Aug 28, 2025: Bertrand William C JR sold 207,000 shares ($2.07K)
- Aug 18, 2025: Behbahani Ali sold 19,500,000 shares ($195K)
- Jul 30, 2025: EcoR1 Capital, LLC sold 64,052,538 shares ($6.74M)